What happens to patients with pulmonary aspergilloma? Analysis of 23 cases.

P Rafferty, BA Biggs, GK Crompton, IWB Grant - Thorax, 1983 - thorax.bmj.com
The problems associated with pulmonary aspergilloma were assessed retrospectively in 23
patients presenting from 1953 to 1982. Haemoptysis occurred in over half the patients and in …

Pyrrolo [2, 3-d] pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I

LD Arnold, DJ Calderwood, RW Dixon… - Bioorganic & medicinal …, 2000 - Elsevier
Pyrrolo [2, 3-d] pyrimidines containing a 5-(4-phenoxyphenyl) substituent are potent and
selective inhibitors of lck in vitro; some compounds are selective for lck over src. Data are …

UK guideline for the use of HIV post-exposure prophylaxis following sexual exposure, 2015

F Cresswell, L Waters, E Briggs, J Fox… - … journal of STD & …, 2016 - journals.sagepub.com
We present the updated British Association for Sexual Health and HIV guidelines for HIV
post-exposure prophylaxis following sexual exposure (PEPSE). This document includes a …

The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5'monophosphate in atopic asthma

P Rafferty, R Beasley, ST Holgate - Am Rev Respir Dis, 1987 - atsjournals.org
In order to Investigate the contribution of histamine to bronchocon8trlctlon provoked by
Inhaled allergen and adenosine monophosph8te (AMP), we halveobserved the effects of …

Effect of a thromboxane receptor antagonist on PGD2-and allergen-induced bronchoconstriction

RC Beasley, RL Featherstone… - Journal of Applied …, 1989 - journals.physiology.org
In this study we investigated the effect of the selective and potent thromboxane A2 (TxA2)
receptor antagonist GR32191 on smooth muscle contraction induced by the TxA2 analogue …

Pyrrolo [2, 3-d] pyrimidines containing diverse N-7 substituents as potent inhibitors of Lck

DJ Calderwood, DN Johnston, R Munschauer… - Bioorganic & Medicinal …, 2002 - Elsevier
A series of pyrrolo [2, 3-d] pyrimidines was synthesized and evaluated as inhibitors of Lck.
Lck accommodates a diverse set of substituents at N-7. Altering the substituent at N-7 …

Pyrrolo [2, 3-d] pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II

AF Burchat, DJ Calderwood, GC Hirst… - Bioorganic & Medicinal …, 2000 - Elsevier
Pyrrolo [2, 3-d] pyrimidines containing a 5-(4-phenoxyphenyl) substituent are novel, potent
and selective inhibitors of lck in vitro. Exploration of C-6 position of the pyrrolo [2, 3-d] …

Pyrazolo [3, 4-d] pyrimidines containing an extended 3-substituent as potent inhibitors of Lck—a selectivity insight

AF Burchat, DJ Calderwood, MM Friedman… - Bioorganic & Medicinal …, 2002 - Elsevier
A series of para-substituted 3-phenyl pyrazolopyrimidines was synthesized and evaluated
as inhibitors of lck. The nature of the substitution affected enzyme selectivity and potency for …

UK guideline for the use of HIV post‐exposure prophylaxis 2021

F Cresswell, K Asanati, S Bhagani, M Boffito… - HIV …, 2022 - Wiley Online Library
We present the updated British Association for Sexual Health and HIV (BASHH) guidelines
for post‐exposure prophylaxis (PEP) to HIV following sexual exposures, occupational …

Thienopyridine urea inhibitors of KDR kinase

HR Heyman, RR Frey, PF Bousquet, GA Cunha… - Bioorganic & medicinal …, 2007 - Elsevier
A series of substituted thienopyridine ureas was prepared and evaluated for enzymatic and
cellular inhibition of KDR kinase activity. Several of these analogs, such as 2, are potent …